Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at care and outcomes for people with Schizophrenia. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
In United States
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is looking at test a meditative neurofeedback intervention for depressed mood for people with Depression - depression or Depression Disorders. Participants take part in MediNF and complete follow-up assessments.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is looking at whether a digital support tool can help people with Mental Health Care, Mental Health, or Depression anxiety. Participants take part in a digital support tool and complete follow-up assessments.
Broader resultThis study is looking at care and outcomes for people with Depression, Anxiety, Suicide, or Drug Use. Some participants may receive Prevention as Usual Control instead of the study treatment, and direct benefit is not guaranteed.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United States
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is comparing Lumateperone with placebo for people with Schizophrenia or Schizo Affective Disorder. Participants receive Lumateperone or placebo and complete study visits and assessments.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is looking at evaluate the ability of methylphenidate to treat PTSD and associated neurocognitive complaints in Veterans for people with PTSD. Participants receive Methylphenidate or placebo and complete study visits and assessments.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.